Logo image of ARQ

ARQ INC (ARQ) Stock Fundamental Analysis

NASDAQ:ARQ - Nasdaq - US00770C1018 - Common Stock - Currency: USD

4.94  -0.15 (-2.95%)

After market: 4.94 0 (0%)

Fundamental Rating

3

Overall ARQ gets a fundamental rating of 3 out of 10. We evaluated ARQ against 85 industry peers in the Chemicals industry. ARQ may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, ARQ is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ARQ had negative earnings in the past year.
ARQ had a positive operating cash flow in the past year.
ARQ had negative earnings in 4 of the past 5 years.
In multiple years ARQ reported negative operating cash flow during the last 5 years.
ARQ Yearly Net Income VS EBIT VS OCF VS FCFARQ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

ARQ has a worse Return On Assets (-0.52%) than 62.35% of its industry peers.
The Return On Equity of ARQ (-0.68%) is comparable to the rest of the industry.
The Return On Invested Capital of ARQ (0.58%) is worse than 76.47% of its industry peers.
Industry RankSector Rank
ROA -0.52%
ROE -0.68%
ROIC 0.58%
ROA(3y)-3.97%
ROA(5y)1.37%
ROE(3y)-5.19%
ROE(5y)0.32%
ROIC(3y)N/A
ROIC(5y)N/A
ARQ Yearly ROA, ROE, ROICARQ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100

1.3 Margins

Looking at the Operating Margin, with a value of 1.65%, ARQ is doing worse than 72.94% of the companies in the same industry.
With a decent Gross Margin value of 36.11%, ARQ is doing good in the industry, outperforming 72.94% of the companies in the same industry.
ARQ's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.65%
PM (TTM) N/A
GM 36.11%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.52%
GM growth 5Y4.26%
ARQ Yearly Profit, Operating, Gross MarginsARQ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 150

More info and screens

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ARQ is destroying value.
The number of shares outstanding for ARQ has been increased compared to 1 year ago.
The number of shares outstanding for ARQ has been increased compared to 5 years ago.
ARQ has a better debt/assets ratio than last year.
ARQ Yearly Shares OutstandingARQ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
ARQ Yearly Total Debt VS Total AssetsARQ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

ARQ has an Altman-Z score of 2.74. This is not the best score and indicates that ARQ is in the grey zone with still only limited risk for bankruptcy at the moment.
ARQ has a Altman-Z score of 2.74. This is in the better half of the industry: ARQ outperforms 75.29% of its industry peers.
A Debt/Equity ratio of 0.12 indicates that ARQ is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.12, ARQ belongs to the best of the industry, outperforming 88.24% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Altman-Z 2.74
ROIC/WACC0.06
WACC9.2%
ARQ Yearly LT Debt VS Equity VS FCFARQ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 1.12 indicates that ARQ should not have too much problems paying its short term obligations.
ARQ has a worse Current ratio (1.12) than 87.06% of its industry peers.
A Quick Ratio of 0.62 indicates that ARQ may have some problems paying its short term obligations.
With a Quick ratio value of 0.62, ARQ is not doing good in the industry: 84.71% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 0.62
ARQ Yearly Current Assets VS Current LiabilitesARQ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 92.59% over the past year.
ARQ shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.32%.
ARQ shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.22% yearly.
EPS 1Y (TTM)92.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)14.32%
Revenue growth 3Y2.8%
Revenue growth 5Y9.22%
Sales Q2Q%25.33%

3.2 Future

Based on estimates for the next years, ARQ will show a very strong growth in Earnings Per Share. The EPS will grow by 65.14% on average per year.
ARQ is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.96% yearly.
EPS Next Y141.32%
EPS Next 2Y124.28%
EPS Next 3Y106.05%
EPS Next 5Y65.15%
Revenue Next Year10.11%
Revenue Next 2Y19.31%
Revenue Next 3Y19.95%
Revenue Next 5Y18.96%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ARQ Yearly Revenue VS EstimatesARQ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M
ARQ Yearly EPS VS EstimatesARQ Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1 1.5 2

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

ARQ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 14.82, which indicates a correct valuation of ARQ.
ARQ's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of ARQ to the average of the S&P500 Index (22.15), we can say ARQ is valued slightly cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 14.82
ARQ Price Earnings VS Forward Price EarningsARQ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150 -200

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ARQ indicates a slightly more expensive valuation: ARQ is more expensive than 70.59% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 20.01
ARQ Per share dataARQ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ARQ's earnings are expected to grow with 106.05% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y124.28%
EPS Next 3Y106.05%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ARQ!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ARQ INC

NASDAQ:ARQ (5/30/2025, 8:00:00 PM)

After market: 4.94 0 (0%)

4.94

-0.15 (-2.95%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)05-07 2025-05-07/bmo
Earnings (Next)08-11 2025-08-11
Inst Owners33.13%
Inst Owner ChangeN/A
Ins Owners19.47%
Ins Owner Change10.36%
Market Cap208.52M
Analysts80
Price Target9.69 (96.15%)
Short Float %3.78%
Short Ratio4.15
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)100%
Min EPS beat(2)100%
Max EPS beat(2)100%
EPS beat(4)3
Avg EPS beat(4)48.59%
Min EPS beat(4)-18.81%
Max EPS beat(4)100%
EPS beat(8)5
Avg EPS beat(8)49.73%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-2.21%
Min Revenue beat(2)-7.12%
Max Revenue beat(2)2.71%
Revenue beat(4)3
Avg Revenue beat(4)7.74%
Min Revenue beat(4)-7.12%
Max Revenue beat(4)22.1%
Revenue beat(8)6
Avg Revenue beat(8)7.5%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)44.43%
EPS NQ rev (3m)-211.13%
EPS NY rev (1m)-35.71%
EPS NY rev (3m)-61.43%
Revenue NQ rev (1m)-6.93%
Revenue NQ rev (3m)-26.87%
Revenue NY rev (1m)-5.23%
Revenue NY rev (3m)-14.67%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 14.82
P/S 1.82
P/FCF N/A
P/OCF 50.27
P/B 0.96
P/tB 0.99
EV/EBITDA 20.01
EPS(TTM)-0.02
EYN/A
EPS(NY)0.33
Fwd EY6.75%
FCF(TTM)-1.78
FCFYN/A
OCF(TTM)0.1
OCFY1.99%
SpS2.71
BVpS5.17
TBVpS4.99
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.52%
ROE -0.68%
ROCE 0.79%
ROIC 0.58%
ROICexc 0.6%
ROICexgc 0.61%
OM 1.65%
PM (TTM) N/A
GM 36.11%
FCFM N/A
ROA(3y)-3.97%
ROA(5y)1.37%
ROE(3y)-5.19%
ROE(5y)0.32%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.52%
GM growth 5Y4.26%
F-Score4
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Debt/EBITDA 2.31
Cap/Depr 877.11%
Cap/Sales 69.42%
Interest Coverage 250
Cash Conversion 37.88%
Profit Quality N/A
Current Ratio 1.12
Quick Ratio 0.62
Altman-Z 2.74
F-Score4
WACC9.2%
ROIC/WACC0.06
Cap/Depr(3y)475.88%
Cap/Depr(5y)322.19%
Cap/Sales(3y)39.34%
Cap/Sales(5y)27.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)92.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y141.32%
EPS Next 2Y124.28%
EPS Next 3Y106.05%
EPS Next 5Y65.15%
Revenue 1Y (TTM)14.32%
Revenue growth 3Y2.8%
Revenue growth 5Y9.22%
Sales Q2Q%25.33%
Revenue Next Year10.11%
Revenue Next 2Y19.31%
Revenue Next 3Y19.95%
Revenue Next 5Y18.96%
EBIT growth 1Y122.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year743.31%
EBIT Next 3Y188.95%
EBIT Next 5Y110.35%
FCF growth 1Y-100.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y116.04%
OCF growth 3Y-26.14%
OCF growth 5Y-29.98%